Return to Article Details
DISEASE MODIFYING ANTI-AMYLOID THERAPIES FOR MILD COGNITIVE IMPAIRMENT / MILD ALZHEIMER’S DISEASE: A NARRATIVE REVIEW OF THE KEY PHASE III CLINICAL TRIALS
Download
Download PDF